MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

Oxford Nanopore Technologies has signed a partnership with artificial intelligence developer SeqOne to support its next-generation sequencing approach in clinical diagnostic testing. The goal will be ...

DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage whole-genome cell-free DNA (cfDNA) assays for cancer detection and monitoring, today announced it will present five ...

Detection Market · GlobeNewswire Inc. The cell-free tumor DNA detection market is set to experience significant growth, ...

-- Milestone marks first of multiple planned diagnostic product launches on NGS roadmap -- Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro ...

New system centralizes at-home DNA testing, biological age assessment, and lab diagnostics into a unified reporting ...

(MENAFN- EIN Presswire) EINPresswire/ -- The DNA Diagnostics Market stood at USD 29.2 billion in 2025 and is forecast to expand to USD 61.9 billion by 2035, reflecting a steady 7.8% CAGR over the ...

DNA can signal the presence of or predisposition to a slew of diseases, including cancer. The ability to flag down these clues, known as biomarkers, allows medical professionals to make critical early ...

DNA can sustain serious injuries called double strand breaks, in which both strands of the helix snap. These breaks are among the most dangerous forms of DNA damage and immediately trigger the cell's ...

Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...

Add Yahoo as a preferred source to see more of our stories on Google. Maury Povich announced a new business venture last week that will help more people learn if they are (or aren't) the father − the ...